Bank Of Montreal Abiomed Inc Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$242.49 - $301.46 $28.7 Million - $35.6 Million	118,215 Added 224.88%	170,783 $42.9 Million
Q2 2022 Aug 11, 2022	BUY	$224.73 - $338.64 $999,823 - $1.51 Million	4,449 Added 9.25%	52,568 $13.5 Million
Q1 2022 May 12, 2022	SELL	$277.25 - $366.29 $1.98 Million - $2.62 Million	-7,148 Reduced 12.93%	48,119 $15.9 Million
Q4 2021 Feb 11, 2022	SELL	$300.63 - $371.35 $8.36 Million - $10.3 Million	-27,814 Reduced 33.48%	55,267 $20.2 Million
Q3 2021 Nov 12, 2021	SELL	$310.19 - $376.2 $3.2 Million - $3.88 Million	-10,314 Reduced 11.04%	83,081 $27.7 Million
Q2 2021 Aug 12, 2021	BUY	$262.71 - $351.17 $24.5 Million - $32.8 Million	93,395 New	93,395 $29.3 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.